# Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma

> **NCT00486135** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 118 (actual)

## Conditions studied

- Cancer
- Lymphoma

## Interventions

- **DRUG:** XL147 (SAR245408)
- **DRUG:** XL147 (SAR245408)

## Key facts

- **NCT ID:** NCT00486135
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2013-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486135, "Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00486135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*